Gervasini, Guillermo <br/><br/>
Polymorphisms in methotrexate pathways: what is clinically relevant, what is not, and what is promising.  [electronic resource] 

 -  Current drug metabolism  Jul 2009 
 - 547-66 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1875-5453 
<br/><br/><label>Standard No.: </label>10.2174/138920009789375414  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Humans<br/>Immunosuppressive Agents--adverse effects<br/>Methotrexate--adverse effects<br/>Pharmacogenetics<br/>Polymorphism, Genetic